 | • レポートコード：QAF27198 • 出版社/出版日：QYResearch / 2021年4月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の血液灌流市場について種類別（活性炭吸着、樹脂吸着）、用途別（肝性脳症、特定自己免疫疾患、薬物過剰摂取、特定中毒、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・血液灌流市場の概要 ・世界の主要地域別血液灌流市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の血液灌流市場規模2016-2021：種類別（活性炭吸着、樹脂吸着） ・世界の血液灌流市場予測2012-2027：種類別（活性炭吸着、樹脂吸着） ・世界の血液灌流市場規模2016-2021：用途別（肝性脳症、特定自己免疫疾患、薬物過剰摂取、特定中毒、その他） ・世界の血液灌流市場予測2012-2027：用途別（肝性脳症、特定自己免疫疾患、薬物過剰摂取、特定中毒、その他） ・血液灌流のアメリカ市場規模と予測2016-2021 ・血液灌流のヨーロッパ市場規模と予測2016-2021 ・血液灌流の中国市場規模と予測2016-2021 ・血液灌流の日本市場規模と予測2016-2021 ・血液灌流の東南アジア市場規模と予測2016-2021 ・血液灌流のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jafron Biomedical、Baxter (Gambro)、Asahi-Kasei、Biosun Medical、Kaneka、Toray Medical、Cytosorbents、Aier、Zibo Kangbei） ・血液灌流の製造コスト分析 ・販売チャネル、流通業者、顧客 ・血液灌流の市場動向・機会・課題 ・調査の結論 |
Hemoperfusion is a treatment technique in which large volumes of the patient’s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
In 2018, the global hemoperfusion products market is led by China. EU is the second-largest region-wise market.
Market Analysis and Insights: Global Hemoperfusion Market
The global Hemoperfusion market was valued at US$ 482.4 in 2020 and will reach US$ 1308.9 million by the end of 2027, growing at a CAGR of 18.1% during 2022-2027.
Global Hemoperfusion Scope and Market Size
The global Hemoperfusion market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemoperfusion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Hepatic Encephalopathy occupies the largest market share of Hepatic Encephalopathy and is the fastest growing
The Hemoperfusion market is analysed and market size information is provided by regions (countries). Segment by Application, the Hemoperfusion market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
1 Hemoperfusion Market Overview
1.1 Hemoperfusion Product Scope
1.2 Hemoperfusion Segment by Type
1.2.1 Global Hemoperfusion Sales by Type (2016 & 2021 & 2027)
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Hemoperfusion Segment by Application
1.3.1 Global Hemoperfusion Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hepatic Encephalopathy
1.3.3 Certain Autoimmune Diseases
1.3.4 Drug Overdose
1.3.5 Specific Intoxications
1.3.6 Others
1.4 Hemoperfusion Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hemoperfusion Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hemoperfusion Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hemoperfusion Price Trends (2016-2027)
2 Hemoperfusion Estimates and Forecasts by Region
2.1 Global Hemoperfusion Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hemoperfusion Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hemoperfusion Sales Market Share by Region (2016-2021)
2.2.2 Global Hemoperfusion Revenue Market Share by Region (2016-2021)
2.3 Global Hemoperfusion Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hemoperfusion Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hemoperfusion Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hemoperfusion Estimates and Projections (2016-2027)
2.4.2 Europe Hemoperfusion Estimates and Projections (2016-2027)
2.4.3 China Hemoperfusion Estimates and Projections (2016-2027)
2.4.4 Japan Hemoperfusion Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hemoperfusion Estimates and Projections (2016-2027)
2.4.6 India Hemoperfusion Estimates and Projections (2016-2027)
3 Global Hemoperfusion Competition Landscape by Players
3.1 Global Top Hemoperfusion Players by Sales (2016-2021)
3.2 Global Top Hemoperfusion Players by Revenue (2016-2021)
3.3 Global Hemoperfusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemoperfusion as of 2020)
3.4 Global Hemoperfusion Average Price by Company (2016-2021)
3.5 Manufacturers Hemoperfusion Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hemoperfusion Market Size by Type
4.1 Global Hemoperfusion Historic Market Review by Type (2016-2021)
4.1.1 Global Hemoperfusion Sales Market Share by Type (2016-2021)
4.1.2 Global Hemoperfusion Revenue Market Share by Type (2016-2021)
4.1.3 Global Hemoperfusion Price by Type (2016-2021)
4.2 Global Hemoperfusion Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hemoperfusion Sales Forecast by Type (2022-2027)
4.2.2 Global Hemoperfusion Revenue Forecast by Type (2022-2027)
4.2.3 Global Hemoperfusion Price Forecast by Type (2022-2027)
5 Global Hemoperfusion Market Size by Application
5.1 Global Hemoperfusion Historic Market Review by Application (2016-2021)
5.1.1 Global Hemoperfusion Sales Market Share by Application (2016-2021)
5.1.2 Global Hemoperfusion Revenue Market Share by Application (2016-2021)
5.1.3 Global Hemoperfusion Price by Application (2016-2021)
5.2 Global Hemoperfusion Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hemoperfusion Sales Forecast by Application (2022-2027)
5.2.2 Global Hemoperfusion Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemoperfusion Price Forecast by Application (2022-2027)
6 North America Hemoperfusion Market Facts & Figures
6.1 North America Hemoperfusion Sales by Company
6.1.1 North America Hemoperfusion Sales by Company (2016-2021)
6.1.2 North America Hemoperfusion Revenue by Company (2016-2021)
6.2 North America Hemoperfusion Sales Breakdown by Type
6.2.1 North America Hemoperfusion Sales Breakdown by Type (2016-2021)
6.2.2 North America Hemoperfusion Sales Breakdown by Type (2022-2027)
6.3 North America Hemoperfusion Sales Breakdown by Application
6.3.1 North America Hemoperfusion Sales Breakdown by Application (2016-2021)
6.3.2 North America Hemoperfusion Sales Breakdown by Application (2022-2027)
7 Europe Hemoperfusion Market Facts & Figures
7.1 Europe Hemoperfusion Sales by Company
7.1.1 Europe Hemoperfusion Sales by Company (2016-2021)
7.1.2 Europe Hemoperfusion Revenue by Company (2016-2021)
7.2 Europe Hemoperfusion Sales Breakdown by Type
7.2.1 Europe Hemoperfusion Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hemoperfusion Sales Breakdown by Type (2022-2027)
7.3 Europe Hemoperfusion Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Hemoperfusion Market Facts & Figures
8.1 China Hemoperfusion Sales by Company
8.1.1 China Hemoperfusion Sales by Company (2016-2021)
8.1.2 China Hemoperfusion Revenue by Company (2016-2021)
8.2 China Hemoperfusion Sales Breakdown by Type
8.2.1 China Hemoperfusion Sales Breakdown by Type (2016-2021)
8.2.2 China Hemoperfusion Sales Breakdown by Type (2022-2027)
8.3 China Hemoperfusion Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Hemoperfusion Market Facts & Figures
9.1 Japan Hemoperfusion Sales by Company
9.1.1 Japan Hemoperfusion Sales by Company (2016-2021)
9.1.2 Japan Hemoperfusion Revenue by Company (2016-2021)
9.2 Japan Hemoperfusion Sales Breakdown by Type
9.2.1 Japan Hemoperfusion Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hemoperfusion Sales Breakdown by Type (2022-2027)
9.3 Japan Hemoperfusion Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hemoperfusion Market Facts & Figures
10.1 Southeast Asia Hemoperfusion Sales by Company
10.1.1 Southeast Asia Hemoperfusion Sales by Company (2016-2021)
10.1.2 Southeast Asia Hemoperfusion Revenue by Company (2016-2021)
10.2 Southeast Asia Hemoperfusion Sales Breakdown by Type
10.2.1 Southeast Asia Hemoperfusion Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hemoperfusion Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hemoperfusion Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Hemoperfusion Market Facts & Figures
11.1 India Hemoperfusion Sales by Company
11.1.1 India Hemoperfusion Sales by Company (2016-2021)
11.1.2 India Hemoperfusion Revenue by Company (2016-2021)
11.2 India Hemoperfusion Sales Breakdown by Type
11.2.1 India Hemoperfusion Sales Breakdown by Type (2016-2021)
11.2.2 India Hemoperfusion Sales Breakdown by Type (2022-2027)
11.3 India Hemoperfusion Sales Breakdown by Application
11.3.1 India Hemoperfusion Sales Breakdown by Application (2016-2021)
11.3.2 India Hemoperfusion Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hemoperfusion Business
12.1 Jafron Biomedical
12.1.1 Jafron Biomedical Corporation Information
12.1.2 Jafron Biomedical Business Overview
12.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jafron Biomedical Hemoperfusion Products Offered
12.1.5 Jafron Biomedical Recent Development
12.2 Baxter (Gambro)
12.2.1 Baxter (Gambro) Corporation Information
12.2.2 Baxter (Gambro) Business Overview
12.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter (Gambro) Hemoperfusion Products Offered
12.2.5 Baxter (Gambro) Recent Development
12.3 Asahi-Kasei
12.3.1 Asahi-Kasei Corporation Information
12.3.2 Asahi-Kasei Business Overview
12.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Asahi-Kasei Hemoperfusion Products Offered
12.3.5 Asahi-Kasei Recent Development
12.4 Biosun Medical
12.4.1 Biosun Medical Corporation Information
12.4.2 Biosun Medical Business Overview
12.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biosun Medical Hemoperfusion Products Offered
12.4.5 Biosun Medical Recent Development
12.5 Kaneka
12.5.1 Kaneka Corporation Information
12.5.2 Kaneka Business Overview
12.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kaneka Hemoperfusion Products Offered
12.5.5 Kaneka Recent Development
12.6 Toray Medical
12.6.1 Toray Medical Corporation Information
12.6.2 Toray Medical Business Overview
12.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Toray Medical Hemoperfusion Products Offered
12.6.5 Toray Medical Recent Development
12.7 Cytosorbents
12.7.1 Cytosorbents Corporation Information
12.7.2 Cytosorbents Business Overview
12.7.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cytosorbents Hemoperfusion Products Offered
12.7.5 Cytosorbents Recent Development
12.8 Aier
12.8.1 Aier Corporation Information
12.8.2 Aier Business Overview
12.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Aier Hemoperfusion Products Offered
12.8.5 Aier Recent Development
12.9 Zibo Kangbei
12.9.1 Zibo Kangbei Corporation Information
12.9.2 Zibo Kangbei Business Overview
12.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zibo Kangbei Hemoperfusion Products Offered
12.9.5 Zibo Kangbei Recent Development
13 Hemoperfusion Manufacturing Cost Analysis
13.1 Hemoperfusion Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hemoperfusion
13.4 Hemoperfusion Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hemoperfusion Distributors List
14.3 Hemoperfusion Customers
15 Market Dynamics
15.1 Hemoperfusion Market Trends
15.2 Hemoperfusion Drivers
15.3 Hemoperfusion Market Challenges
15.4 Hemoperfusion Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hemoperfusion Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hemoperfusion Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hemoperfusion Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hemoperfusion Sales (K Units) by Region (2016-2021)
Table 5. Global Hemoperfusion Sales Market Share by Region (2016-2021)
Table 6. Global Hemoperfusion Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hemoperfusion Revenue Share by Region (2016-2021)
Table 8. Global Hemoperfusion Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Hemoperfusion Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hemoperfusion Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hemoperfusion Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hemoperfusion Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Hemoperfusion Sales Share by Company (2016-2021)
Table 14. Global Hemoperfusion Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hemoperfusion Revenue Share by Company (2016-2021)
Table 16. Global Hemoperfusion by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoperfusion as of 2020)
Table 17. Global Hemoperfusion Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Hemoperfusion Manufacturing Sites and Area Served
Table 19. Manufacturers Hemoperfusion Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hemoperfusion Sales (K Units) by Type (2016-2021)
Table 22. Global Hemoperfusion Sales Share by Type (2016-2021)
Table 23. Global Hemoperfusion Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hemoperfusion Price (USD/Unit) by Type (2016-2021)
Table 25. Global Hemoperfusion Sales Share by Type (2022-2027)
Table 26. Global Hemoperfusion Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hemoperfusion Revenue Share by Type (2022-2027)
Table 28. Global Hemoperfusion Price (USD/Unit) by Type (2022-2027)
Table 29. Global Hemoperfusion Sales (K Units) by Application (2016-2021)
Table 30. Global Hemoperfusion Sales Share by Application (2016-2021)
Table 31. Global Hemoperfusion Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hemoperfusion Price (USD/Unit) by Application (2016-2021)
Table 33. Global Hemoperfusion Sales (K Units) by Application (2022-2027)
Table 34. Global Hemoperfusion Sales Share by Application (2022-2027)
Table 35. Global Hemoperfusion Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hemoperfusion Revenue Share by Application (2022-2027)
Table 37. Global Hemoperfusion Price (USD/Unit) by Application (2022-2027)
Table 38. North America Hemoperfusion Sales (K Units) by Company (2016-2021)
Table 39. North America Hemoperfusion Sales Market Share by Company (2016-2021)
Table 40. North America Hemoperfusion Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hemoperfusion Revenue Market Share by Company (2016-2021)
Table 42. North America Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 43. North America Hemoperfusion Sales Market Share by Type (2016-2021)
Table 44. North America Hemoperfusion Sales by Type (2022-2027) & (K Units)
Table 45. North America Hemoperfusion Sales Market Share by Type (2022-2027)
Table 46. North America Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 47. North America Hemoperfusion Sales Market Share by Application (2016-2021)
Table 48. North America Hemoperfusion Sales by Application (2022-2027) & (K Units)
Table 49. North America Hemoperfusion Sales Market Share by Application (2022-2027)
Table 50. Europe Hemoperfusion Sales (K Units) by Company (2016-2021)
Table 51. Europe Hemoperfusion Sales Market Share by Company (2016-2021)
Table 52. Europe Hemoperfusion Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hemoperfusion Revenue Market Share by Company (2016-2021)
Table 54. Europe Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 55. Europe Hemoperfusion Sales Market Share by Type (2016-2021)
Table 56. Europe Hemoperfusion Sales by Type (2022-2027) & (K Units)
Table 57. Europe Hemoperfusion Sales Market Share by Type (2022-2027)
Table 58. Europe Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 59. Europe Hemoperfusion Sales Market Share by Application (2016-2021)
Table 60. Europe Hemoperfusion Sales by Application (2022-2027) & (K Units)
Table 61. Europe Hemoperfusion Sales Market Share by Application (2022-2027)
Table 62. China Hemoperfusion Sales (K Units) by Company (2016-2021)
Table 63. China Hemoperfusion Sales Market Share by Company (2016-2021)
Table 64. China Hemoperfusion Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hemoperfusion Revenue Market Share by Company (2016-2021)
Table 66. China Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 67. China Hemoperfusion Sales Market Share by Type (2016-2021)
Table 68. China Hemoperfusion Sales by Type (2022-2027) & (K Units)
Table 69. China Hemoperfusion Sales Market Share by Type (2022-2027)
Table 70. China Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 71. China Hemoperfusion Sales Market Share by Application (2016-2021)
Table 72. China Hemoperfusion Sales by Application (2022-2027) & (K Units)
Table 73. China Hemoperfusion Sales Market Share by Application (2022-2027)
Table 74. Japan Hemoperfusion Sales (K Units) by Company (2016-2021)
Table 75. Japan Hemoperfusion Sales Market Share by Company (2016-2021)
Table 76. Japan Hemoperfusion Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hemoperfusion Revenue Market Share by Company (2016-2021)
Table 78. Japan Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 79. Japan Hemoperfusion Sales Market Share by Type (2016-2021)
Table 80. Japan Hemoperfusion Sales by Type (2022-2027) & (K Units)
Table 81. Japan Hemoperfusion Sales Market Share by Type (2022-2027)
Table 82. Japan Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 83. Japan Hemoperfusion Sales Market Share by Application (2016-2021)
Table 84. Japan Hemoperfusion Sales by Application (2022-2027) & (K Units)
Table 85. Japan Hemoperfusion Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hemoperfusion Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Hemoperfusion Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hemoperfusion Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hemoperfusion Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Hemoperfusion Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hemoperfusion Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Hemoperfusion Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Hemoperfusion Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hemoperfusion Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Hemoperfusion Sales Market Share by Application (2022-2027)
Table 98. India Hemoperfusion Sales (K Units) by Company (2016-2021)
Table 99. India Hemoperfusion Sales Market Share by Company (2016-2021)
Table 100. India Hemoperfusion Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hemoperfusion Revenue Market Share by Company (2016-2021)
Table 102. India Hemoperfusion Sales by Type (2016-2021) & (K Units)
Table 103. India Hemoperfusion Sales Market Share by Type (2016-2021)
Table 104. India Hemoperfusion Sales by Type (2022-2027) & (K Units)
Table 105. India Hemoperfusion Sales Market Share by Type (2022-2027)
Table 106. India Hemoperfusion Sales by Application (2016-2021) & (K Units)
Table 107. India Hemoperfusion Sales Market Share by Application (2016-2021)
Table 108. India Hemoperfusion Sales by Application (2022-2027) & (K Units)
Table 109. India Hemoperfusion Sales Market Share by Application (2022-2027)
Table 110. Jafron Biomedical Corporation Information
Table 111. Jafron Biomedical Description and Business Overview
Table 112. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Jafron Biomedical Hemoperfusion Product
Table 114. Jafron Biomedical Recent Development
Table 115. Baxter (Gambro) Corporation Information
Table 116. Baxter (Gambro) Description and Business Overview
Table 117. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Baxter (Gambro) Hemoperfusion Product
Table 119. Baxter (Gambro) Recent Development
Table 120. Asahi-Kasei Corporation Information
Table 121. Asahi-Kasei Description and Business Overview
Table 122. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Asahi-Kasei Hemoperfusion Product
Table 124. Asahi-Kasei Recent Development
Table 125. Biosun Medical Corporation Information
Table 126. Biosun Medical Description and Business Overview
Table 127. Biosun Medical Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Biosun Medical Hemoperfusion Product
Table 129. Biosun Medical Recent Development
Table 130. Kaneka Corporation Information
Table 131. Kaneka Description and Business Overview
Table 132. Kaneka Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Kaneka Hemoperfusion Product
Table 134. Kaneka Recent Development
Table 135. Toray Medical Corporation Information
Table 136. Toray Medical Description and Business Overview
Table 137. Toray Medical Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Toray Medical Hemoperfusion Product
Table 139. Toray Medical Recent Development
Table 140. Cytosorbents Corporation Information
Table 141. Cytosorbents Description and Business Overview
Table 142. Cytosorbents Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Cytosorbents Hemoperfusion Product
Table 144. Cytosorbents Recent Development
Table 145. Aier Corporation Information
Table 146. Aier Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Aier Description and Business Overview
Table 148. Aier Hemoperfusion Product
Table 149. Aier Recent Development
Table 150. Zibo Kangbei Corporation Information
Table 151. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Zibo Kangbei Description and Business Overview
Table 153. Zibo Kangbei Hemoperfusion Product
Table 154. Zibo Kangbei Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Hemoperfusion Distributors List
Table 158. Hemoperfusion Customers List
Table 159. Hemoperfusion Market Trends
Table 160. Hemoperfusion Market Drivers
Table 161. Hemoperfusion Market Challenges
Table 162. Hemoperfusion Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemoperfusion Product Picture
Figure 2. Global Hemoperfusion Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hemoperfusion Sales Market Share by Application in 2021 & 2027
Figure 6. Hepatic Encephalopathy Examples
Figure 7. Certain Autoimmune Diseases Examples
Figure 8. Drug Overdose Examples
Figure 9. Specific Intoxications Examples
Figure 10. Others Examples
Figure 11. Global Hemoperfusion Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemoperfusion Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Hemoperfusion Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Hemoperfusion Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Hemoperfusion Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Hemoperfusion Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Hemoperfusion Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Hemoperfusion Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Hemoperfusion Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Hemoperfusion Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Hemoperfusion Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Hemoperfusion Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Hemoperfusion Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Hemoperfusion Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Hemoperfusion Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Hemoperfusion Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Hemoperfusion Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Hemoperfusion Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Hemoperfusion Players Market Share by Revenue in Hemoperfusion: 2016 & 2020
Figure 30. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Hemoperfusion Revenue Share by Type (2016-2021)
Figure 32. Global Hemoperfusion Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Hemoperfusion Revenue Share by Application (2016-2021)
Figure 34. Global Hemoperfusion Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Hemoperfusion Sales Market Share by Type in 2020
Figure 36. North America Hemoperfusion Sales Market Share by Application in 2020
Figure 37. Europe Hemoperfusion Sales Market Share by Type in 2020
Figure 38. Europe Hemoperfusion Sales Market Share by Application in 2020
Figure 39. China Hemoperfusion Sales Market Share by Type in 2020
Figure 40. China Hemoperfusion Sales Market Share by Application in 2020
Figure 41. Japan Hemoperfusion Sales Market Share by Type in 2020
Figure 42. Japan Hemoperfusion Sales Market Share by Application in 2020
Figure 43. Southeast Asia Hemoperfusion Sales Market Share by Type in 2020
Figure 44. Southeast Asia Hemoperfusion Sales Market Share by Application in 2020
Figure 45. India Hemoperfusion Sales Market Share by Type in 2020
Figure 46. India Hemoperfusion Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Hemoperfusion
Figure 49. Manufacturing Process Analysis of Hemoperfusion
Figure 50. Hemoperfusion Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
血液灌流用生産品のグローバル市場2021 Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material an…- 血液灌流のグローバル市場調査 2019年 The global Hemoperfusion market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hemoperfusion volume and value at global level, regional level and company level. From a global perspective, this report repr…
- 使い捨て血液灌流のグローバル市場2021 Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material an…
- 世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年） Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria. Market Analysis and Insights: Global Acute Hepatic Porphyria Drug Market The global Acute Hepatic Porphyria Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
- 肝性脳症薬のグローバル市場調査 2019年 The global Hepatic Encephalopathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hepatic Encephalopathy Drug volume and value at global level, regional level and company level. From a global p…